[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZHANG et al., 2009 - Google Patents

'true're‐infection of Helicobacter pylori after successful eradication–worldwide annual rates, risk factors and clinical implications

ZHANG et al., 2009

View PDF
Document ID
16811422807014108569
Author
ZHANG Y
XIA H
ZHUANG Z
Zhong J
Publication year
Publication venue
Alimentary pharmacology & therapeutics

External Links

Snippet

Background The incidence of 'true're‐infection with Helicobacter pylori after successful eradication remains uncertain. Aim To determine the worldwide rates, risk factors and clinical implications of 'true're‐infection of Helicobacter pylori.'True're‐infection of H. pylori is …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6888Hybridisation probes for detection or identification of organisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Micro-organisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/105Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
ZHANG et al. ‘true’re‐infection of Helicobacter pylori after successful eradication–worldwide annual rates, risk factors and clinical implications
Stefano et al. Helicobacter pylori, transmission routes and recurrence of infection: state of the art
Oh et al. The effect of probiotics on gut microbiota during the Helicobacter pylori eradication: randomized controlled trial
Thirumurthi et al. Helicobacter pylori infection in India from a western perspective
Sun et al. Helicobacter pylori recrudescence and its influencing factors
Leja et al. Epidemiology of Helicobacter pylori infection
Herrera et al. Helicobacter pylori and gastric adenocarcinoma
Malaty Epidemiology of Helicobacter pylori infection.
Jin et al. Systematic review and meta‐analysis from Chinese literature: the association between Helicobacter pylori eradication and improvement of functional dyspepsia
Montes et al. Helicobacter pylori infection in children. Antimicrobial resistance and treatment response
Picoli et al. Resistance to amoxicillin, clarithromycin and ciprofloxacin of Helicobacter pylori isolated from Southern Brazil patients
Bahadori et al. Presence of gastric Helicobacter species in children suffering from gastric disorders in Southern Turkey
Ismail et al. A newly developed nested PCR assay for the detection of Helicobacter pylori in the oral cavity
Streit et al. Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003)
Yari et al. Loop‐mediated isothermal amplification as a fast noninvasive method of helicobacter pylori diagnosis
Pietroiusti et al. Helicobacter pylori duodenal colonization is a strong risk factor for the development of duodenal ulcer
Taneike et al. Analysis of drug resistance and virulence‐factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status?
Lee et al. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan
Hamidi et al. Antibiotic resistance and clonal relatedness of Helicobacter pylori strains isolated from stomach biopsy specimens in northeast of Iran
Yula et al. Detection of primary clarithromycin resistance of Helicobacter pylori and association between cagA+ status and clinical outcome
Adachi et al. Reinfection rate following effective therapy against Helicobacter pylori infection in Japan
Ahmad et al. Analysis of antibiotic susceptibility patterns of Helicobacter pylori isolates from Malaysia
Mendoza-Elizalde et al. Analysis of the genotypic diversity of strains of Helicobacter pylori isolated from pediatric patients in Mexico
Reyna-Fabián et al. Analysis of the bacterial diversity in liver abscess: differences between pyogenic and amebic abscesses
Keshavarz Azizi Raftar et al. The Helicobacter pylori resistance rate to clarithromycin in Iran